CoCensys

Cocensys email format

Verified email-pattern data for Cocensys is currently limited. You can still use the company insights and contact sections below.
CoCensys was founded in 1989 with a successful IPO in 1993, it acquired ACEA Pharmaceuticals in 1994, divested its Sales and Marketing Division to Watson Pharmaceuticals in 1997, and was acquired by Purdue Pharma in 1999. CoCensys developed allosteric modulators of the GABA-A receptor, modulators of NMDA and AMPA receptors, and sodium channel blockers with equipotent inhibitory actions at NaV1.8 and NaV1.6 isoforms. It had co-development and licensing agreements with Novartis, Parke-Davis, Searle, and Wyeth-Ayerst. The neuroactive steroid ganaxolone, a positive allosteric modulator of GABA-A receptors, is currently in Phase 3 development by Marinus Pharmaceuticals.

Company Details

Founded
-
Address
213 Technology Drive, Irvine,ca 92618,united States
Industry
Pharmaceutical Manufacturing
HQ
Irvine, CA
Looking for a particular CoCensys employee's phone or email?

Cocensys Questions

Explore related pages

Related company profiles:

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant